1211 EMERGENCE AND PERSISTENCE OF NS5B MUTATIONS FOLLOWING COMBINATION TREATMENT WITH TEGOBUVIR (GS-9190) PLUS STANDARD OF CARE-LONG-TERM FOLLOW-UP FROM THE PHASE IIB STUDY GS-US-196-0103
Hebner, C., Harris, J., Oldach, D., Miller, M.D., Mo, H.Volume:
54
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(11)61213-0
Date:
March, 2011
File:
PDF, 59 KB
english, 2011